ALP — Alpha Compute Share News
0.000.00%
Last trade - 00:00- $4.68m
- $2.32m
- $0.10m
Portage Biotech soars on potential deal with Immunova
Brief: Portage Biotech Announces Letter Of Intent With Immunova For An Option To Acquire Iox Therapeutics
Brief: Portage Biotech Says CFO Allan Shaw Departed From Co
Brief: Portage Biotech Regains Compliance With Nasdaq Listing Rule 5550(A)(2)
Brief: Portage Biotech Announces 1-For-20 Reverse Stock Split
Brief: Portage Biotech Plans To Expand Its Evaluation Of Strategic Alternatives
Brief: Immuno-Oncology Company Portage Biotech Completes Monetization of Intensity Therapeutics Shares
Portage Biotech Inc reports results for the quarter ended in December - Earnings Summary
Portage Biotech Inc expected to post a loss of 27 cents a share - Earnings Preview
Brief: Portage Biotech Reports Business And Strategic Update
Brief: Portage Biotech Collaborates With Merck To Study 2 Next-Gen Adenosine Antagonists In Combination With Keytruda In Solid Tumors
Portage Biotech Inc reports results for the quarter ended in June - Earnings Summary
Portage Biotech Inc expected to post a loss of 24 cents a share - Earnings Preview
Portage Biotech Inc expected to post a loss of 27 cents a share - Earnings Preview
Brief: Portage Biotech Announces First Patient Dosed In Phase 1A Trial Of PORT-6 In Select Solid Tumors
U.S. STOCKS ON THE MOVE-Spotify, Akero Therapeutics, Cyxtera Technologies
U.S. STOCKS ON THE MOVE-Tesla, Moderna, Oil tanker firms
Brief: Portage Biotech Reports Updated Interim Data For Cancer Treatment
Portage Biotech rises on interim data from cancer treatment trial